Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients.

Publication

Citation
Sarabu R, Bizzarro FT, Corbett WL, Dvorozniak MT, Geng W, Grippo JF, Haynes NE, Hutchings S, Garofalo L, Guertin KR, Hilliard DW, Kabat M, Kester RF, Ka W, Liang Z, Mahaney PE, Marcus L, Matschinsky FM, Moore D, Racha J, Radinov R, Ren Y, Qi L, Pignatello M, Spence CL, Steele T, Tengi J, Grimsby J.: Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients. J Med Chem, Volume 55 (16), 2012
Authors
Bizzarro FT, Corbett WL, Dvorozniak MT, Garofalo L, Geng W, Grimsby J., Grippo JF, Guertin KR, Haynes NE, Hilliard DW, Hutchings S, Ka W, Kabat M, Kester RF, Liang Z, Mahaney PE, Marcus L, Matschinsky FM, Moore D, Pignatello M, Qi L, Racha J, Radinov R, Ren Y, Sarabu R, Spence CL, Steele T, Tengi J
Journal
J Med Chem
Year
2012
PubMed
22809456
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc